Compugen (CGEN) Revenue (2009 - 2026)
Compugen recorded quarterly Revenue of $2.2 million in Q1 2026, down 4.73% quarter-over-quarter from $2.3 million in Q1 2025, and down 4.73% year-over-year from $2.3 million in Q1 2025.
Compugen's Revenue history runs 2 years deep, the most recent figure standing at $2.2 million for Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 67.33 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 2.28 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 17.13 Mn |
| Jun 30, 2024 | 6.70 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Dec 31, 2023 | 33.46 Mn |
| Dec 31, 2022 | 7.50 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Sep 30, 2018 | 7.80 Mn |
| Dec 31, 2016 | 53,000.00 |
| Sep 30, 2016 | 70,000.00 |
| Jun 30, 2016 | 496,000.00 |
| Mar 31, 2016 | 93,000.00 |
| Dec 31, 2015 | 8.31 Mn |
| Sep 30, 2015 | 229,000.00 |
| Jun 30, 2015 | 223,000.00 |
| Mar 31, 2015 | 513,000.00 |
| Dec 31, 2014 | 6.55 Mn |
| Sep 30, 2014 | 1.72 Mn |
| Jun 30, 2014 | 1.96 Mn |
| Mar 31, 2014 | 2.13 Mn |
| Dec 31, 2013 | 1.78 Mn |
| Sep 30, 2013 | 1.59 Mn |
| Jun 30, 2013 | 22,000.00 |
| Mar 31, 2013 | 162,000.00 |
| Dec 31, 2012 | 134,000.00 |
| Sep 30, 2012 | 108,000.00 |
| Dec 31, 2010 | 190,000.00 |
| Jun 30, 2010 | 800,000.00 |
| Mar 31, 2010 | 125,000.00 |
| Dec 31, 2009 | 25,000.00 |
| Sep 30, 2009 | -96,000.00 |